• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • Past Event

OHE Annual Lecture 2018: Is There an Economic Case for Investing in the NHS? Really?

Join OHE for an evening lecture with Professor Peter Smith on Tuesday, 4 September 2018, at the Royal College of Physicians, London. The recent debate over funding has highlighted the difficulty of persuading sceptics that the NHS is a good…

Date

09/03/18 11:00 pm

Join OHE for an evening lecture with Professor Peter Smith on Tuesday, 4 September 2018, at the Royal College of Physicians, London.

The recent debate over funding has highlighted the difficulty of persuading sceptics that the NHS is a good use of public finance. The UK government’s decision to increase NHS England’s budget by £20bn in real terms by 2023 is widely regarded as not enough by Think Tanks, as well as by the National Audit Office and the Office for Budget Responsibility. Yet in the UK and elsewhere, there is a widely held view – particularly in finance ministries and some sections of the media – that health systems such as the NHS are ‘black holes’, constantly demanding increased funding without concomitant returns to society. The £20bn has met resistance, notably from the UK Treasury, which believes the NHS could be more efficient and that there will be little to see from the £20bn. 
 
Professor Peter Smith will argue that an economic case can be made for investment in the NHS. But it is not straightforward and will involve changes in the way the NHS thinks about itself. He will test the validity of the scepticism about “black holes”, and offer a framework for a more informed debate about the contribution of the NHS to national wellbeing.  He will examine the objectives of HM Treasury, and assess the extent to which increased NHS funding can promote such objectives. The presentation presents two broad categories of response that the Department of Health and Social Care might adopt in order to dispel some of the scepticism:
  • The first involves reframing how the benefits of the NHS are presented, in a way that underlines its broader contribution to society, beyond the traditional medical role. Perhaps the most obvious need in this respect is to develop better metrics of efficiency, to demonstrate that the NHS is making good use of public funds. However, there are many other broader contributions that could be better highlighted. For example, the NHS offers the population very strong protection from the financial risk caused by possibly catastrophic medical expenditure. Yet health policymakers have been very coy about articulating the nature and value of such protection.
  • The second and more challenging type of response is to reconsider some of the NHS priorities, so as to align its actions more closely with general social objectives. For example, increased attention to the major causes of disability amongst working age people – such as musculoskeletal disorders and mental illness – could make a major contribution to helping people stay in the workforce and improving national productivity. Likewise, attaching a higher priority to improving the health-related quality of life amongst older people might extend their working lives, enable them to make richer contributions to society after retirement, reduce their need for support from other social programmes such as social care, and reduce the informal burden of caregiving assumed by families and friends. 
Professor Smith will argue that the, in formulating its priorities, the NHS needs to think much more about these broader social consequences of its actions, which were central to the original Beveridge vision. It will assess the evidence base on which such policies could be based and discuss the extent to which the necessary actions might be feasible and effective.
 
Peter C. Smith is Professor of Global Health Economics at the University of York and Emeritus Professor of Health Policy at Imperial College Business School. He is a mathematics graduate from the University of Oxford, and started his academic career in the public health department at the University of Cambridge. He is a health economist with research interests that include the financing, efficiency and performance of health systems and the broader public services, with a particular interest in the link between evidence and policy. He worked at the University of York for 25 years including serving as Director of the Centre for Health Economics, before moving to Imperial College Business School, where he launched and co-directed the Centre for Health Policy in the Institute of Global Health Innovation.
 
With colleagues he has published widely on health economics and related topics, including over 150 refereed papers and 14 books as author or editor, including the Oxford Handbook of Health Economics.
 
Peter has acted in numerous UK governmental advisory capacities, and is currently chair of the NHS Advisory Committee on Resource Allocation. He was previously a board member of the Audit Commission and a member of the HM Treasury Expert Panel on Variations in Public Sector Performance. He has also advised many overseas governments and international agencies, including the World Health Organization, the International Monetary Fund, the World Bank, the Inter-American Development Bank, the Global Fund, the European Commission and the Organization for Economic Cooperation and Development.
 
Registration for this event is via Eventbrite.
 

Related Events

ValueofVacc_JoinedImage
  • Past Event
  • OHE Webinar
  • January 2023

The Value of Vaccines and Taskforces

Read more
Vaccines,Lockdowns Webinar
  • Past Event
  • OHE Webinar
  • January 2023

Vaccines, Antivirals, Lockdowns and COVID: Lessons from the Pandemic

Read more
Insights2022-2023
  • Past Event
  • OHE Webinar
  • January 2023

Insights From 2022 and Emerging Issues in 2023

Read more
Annual Lecture
  • Past Event
  • October 2022

Universal Health Coverage: More Than Just Old Wine in a New Bottle?

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!